Patents by Inventor Eberhard Hildt

Eberhard Hildt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polypeptide mediating cell permeability
    Patent number: 7262267
    Abstract: The present invention relates to a cell-permeable polypeptide that can mediate cell permeability to substances, DNA coding for said polypeptide and a method for the production of said polypeptide. The invention also relates to antibodies directed against the polypeptide and the use of said polypeptide in the mediation of cell permeability to substances.
    Type: Grant
    Filed: November 3, 1999
    Date of Patent: August 28, 2007
    Assignee: Island Pharmacueticals, Ltd.
    Inventors: Eberhard Hildt, Stephanie Schmidt
  • Increasing of the resorption of substances via skin and mucous membranes
    Publication number: 20070172516
    Abstract: The invention relates to the increasing of the resorption of substances via skin and mucous membranes. The invention also relates to substances having an increased capability of being resorbed by skin and mucous membranes, and to pharmaceutical compositions containing substances of this type.
    Type: Application
    Filed: September 3, 2003
    Publication date: July 26, 2007
    Applicant: ProCom Biotechnologische Produktions GmbH
    Inventors: Trutz Podschun, Peter Hofschneider, Eberhard Hildt
  • Particles for gene therapy
    Patent number: 7018826
    Abstract: The present invention relates to particles, comprising: a protein envelope with a fusion protein, which comprises a virus protein, a cell permeability-mediating peptide and a heterologous cell-specific binding site; and a nucleic acid present in the protein envelope, which comprises the sequence for a virus-specific packaging signal and a structural gene. The invention further relates to methods for the preparation of such particles and means suitable for this purpose, as well as the use of the particles in gene therapy.
    Type: Grant
    Filed: February 4, 2000
    Date of Patent: March 28, 2006
    Assignee: Island Pharmaceuticals Ltd.
    Inventors: Eberhard Hildt, Peter Hofschneider